Cognetivity Neurosciences Ltd. Stock
Stocks
CGNSF
CA19243C1005
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
OTC Markets
03:57:37 2026-10-09 pm EDT
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | 0.00% |
|
0.00% | - |
| Market Cap | 1.2M 855K 764K 706K 640K 81.24M 1.22M 8.49M 3.36M 42.53M 3.21M 3.14M 134M | P/E 2022 |
-2.9x | P/E 2023 | -2.8x |
|---|---|---|---|---|---|
| Enterprise Value | 245K 175K 156K 144K 131K 16.62M 249K 1.74M 686K 8.7M 657K 643K 27.46M | EV / Sales 2022 |
-
| EV / Sales 2023 | 437,922,999x |
| Free-Float |
85.56% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 month | 0 | 0 | |
| Current year | 0 | 0 | |
| 1 year | 0 | 0 | |
| 3 years | 0 | 0.12 | |
| 5 years | 0 | 0.62 | |
| 10 years | 0 | 1.12 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sina Habibi
CEO | Chief Executive Officer | 45 | 2013-03-31 |
Mark Phillips
CMP | Compliance Officer | 67 | 2017-12-20 |
| Director | Title | Age | Since |
|---|---|---|---|
Sina Habibi
BRD | Director/Board Member | 45 | 2016-12-31 |
Mark Phillips
BRD | Director/Board Member | 67 | 2017-12-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/15/24 | Option | Founder | 600,000 | 0.6697% | ||
| 4/15/24 | Option | Founder | 600,000 | 0.6697% | ||
| 6/23/23 | Sell | Founder | 1,108,160 | 1.3030% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | - | - | 93 | ||
| -0.40% | -2.34% | +17.82% | +45.91% | 249B | ||
| +0.33% | +0.64% | +3.49% | +12.96% | 162B | ||
| +1.90% | +6.00% | -17.96% | +65.92% | 157B | ||
| -0.70% | +2.93% | -55.38% | -8.86% | 66.22B | ||
| +0.15% | +4.09% | +10.82% | +65.55% | 52.3B | ||
| +0.24% | +0.99% | -15.19% | -10.88% | 52.18B | ||
| -1.13% | +2.85% | +16.39% | +28.99% | 51.34B | ||
| -0.47% | +0.06% | +17.37% | +58.29% | 48.79B | ||
| -0.42% | +3.83% | +27.55% | +77.45% | 44.57B | ||
| Average | -0.05% | +2.04% | +0.54% | +37.26% | 88.35B | |
| Weighted average by Cap. | +0.14% | +1.50% | +1.37% | +38.41% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | - | 0.05 0.03 0.03 0.03 0.02 3.07 0.05 0.32 0.13 1.61 0.12 0.12 5.08 |
| Net income | -13.13M -9.37M -8.37M -7.73M -7.01M -890M -13.34M -93.02M -36.76M -466M -35.17M -34.43M -1.47B | -7.43M -5.3M -4.74M -4.38M -3.97M -504M -7.55M -52.67M -20.81M -264M -19.92M -19.5M -832M |
| Net Debt | -82.43K -58.82K -52.55K -48.55K -44.02K -5.59M -83.75K -584K -231K -2.93M -221K -216K -9.23M | -953K -680K -608K -562K -509K -64.62M -969K -6.76M -2.67M -33.83M -2.55M -2.5M -107M |
Employees
-
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CGNSF Stock
Select your edition
All financial news and data tailored to specific country editions
















